BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zuckerman JN. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol. 2007;79:919-921. [PMID: 17516515 DOI: 10.1002/jmv.20816] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Zhou L, Yu Y, Zhu Z, Lin C, Lu C, Yang R. Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody. Diagn Microbiol Infect Dis 2009;63:165-72. [PMID: 19150709 DOI: 10.1016/j.diagmicrobio.2008.10.020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
2 Ding Y, Ma L, Wang XZ, Zhang J, Zhao GZ, Wang ZQ, Dou XG. In vitro study on hepatitis B virus infecting human choriocarcinoma JEG3 cells and its mechanism. Intervirology 2011;54:276-81. [PMID: 21454957 DOI: 10.1159/000324528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lai M, Liaw Y. Chronic Hepatitis B: Past, Present, and Future. Clinics in Liver Disease 2010;14:531-46. [DOI: 10.1016/j.cld.2010.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
4 Bacq Y. Hépatite virale B et Grossesse. Gastroentérologie Clinique et Biologique 2008;32:S12-9. [DOI: 10.1016/s0399-8320(08)73260-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Jazayeri SM, Alavian SM, Dindoost P, Thomas HC, Karayiannis P. Molecular Variants of Hepatitis B Surface Antigen (HBsAg). In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 107-26. [DOI: 10.1002/9781118637272.ch8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Abbas Z, Siddiqui AR. Management of hepatitis B in developing countries. World J Hepatol 2011; 3(12): 292-299 [PMID: 22216369 DOI: 10.4254/wjh.v3.i12.292] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
7 Bacq Y, Gaudy-Graffin C, Marchand S. [Prophylaxis of mother-to-infant transmission of hepatitis B virus]. Arch Pediatr. 2015;22:427-434. [PMID: 25725975 DOI: 10.1016/j.arcped.2014.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Zankharia US, Kudchodkar S, Khoshnejad M, Perales-Puchalt A, Choi H, Ho M, Zaidi F, Ugen KE, Kim JJ, Weiner DB, Muthumani K. Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody. Hum Vaccin Immunother 2020;16:2156-64. [PMID: 32463327 DOI: 10.1080/21645515.2020.1763686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ma L, Wang X, Bi X, Yang J, Shi B, He X, Ma R, Ma Q, Yao X. Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine. PLoS One. 2017;12:e0170479. [PMID: 28114326 DOI: 10.1371/journal.pone.0170479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Rizzetto M, Ciancio A. Chronic HBV-related liver disease. Mol Aspects Med. 2008;29:72-84. [PMID: 18067957 DOI: 10.1016/j.mam.2007.09.013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
11 Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016;23:taw058. [PMID: 27625399 DOI: 10.1093/jtm/taw058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
12 Hu Y, Wu Q, Xu B, Zhou Z, Wang Z, Zhou YH. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants. Vaccine 2008;26:6064-7. [PMID: 18812198 DOI: 10.1016/j.vaccine.2008.09.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
13 Brook G, Soriano V, Bergin C. European guideline for the management of hepatitis B and C virus infections, 2010. Int J STD AIDS 2010;21:669-78. [DOI: 10.1258/ijsa.2010.010234] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
14 Jones ME, Tully JM. Hepatitis B prophylaxis in adolescents who present for examination after alleged sexual assault. J Paediatr Child Health 2020;56:1178-84. [PMID: 32162752 DOI: 10.1111/jpc.14860] [Reference Citation Analysis]
15 Brook G, Brockmeyer N, van de Laar T, Schellberg S, Winter AJ. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings. Int J STD AIDS 2018;29:949-67. [PMID: 29716442 DOI: 10.1177/0956462418767576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Zhang Z, Chen C, Li Z, Wu YH, Xiao XM. Individualized management of pregnant women with high hepatitis B virus DNA levels. World J Gastroenterol 2014; 20(34): 12056-12061 [PMID: 25232243 DOI: 10.3748/wjg.v20.i34.12056] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
17 Greek R, Menache A, Rice MJ. Animal models in an age of personalized medicine. Per Med 2012;9:47-64. [PMID: 29783296 DOI: 10.2217/pme.11.89] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
18 Orlando R, Foggia M, Maraolo AE, Mascolo S, Palmiero G, Tambaro O, Tosone G. Prevention of hepatitis B virus infection: from the past to the future. Eur J Clin Microbiol Infect Dis. 2015;34:1059-1070. [PMID: 25678010 DOI: 10.1007/s10096-015-2341-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
19 Brook G, Bhagani S, Kulasegaram R, Torkington A, Mutimer D, Hodges E, Hesketh L, Farnworth S, Sullivan V, Gore C, Devitt E, Sullivan AK; Clinical Effectiveness Group British Association for Sexual Health and HIV. United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015. Int J STD AIDS 2016;27:501-25. [PMID: 26745988 DOI: 10.1177/0956462415624250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
20 Tan HH, Martin P. Management of end-stage liver disease in chronic hepatitis B. Clin Liver Dis. 2010;14:477-493. [PMID: 20638026 DOI: 10.1016/j.cld.2010.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
21 Tiwari A, Sankhyan A, Khanna N, Sinha S. Enhanced periplasmic expression of high affinity humanized scFv against Hepatitis B surface antigen by codon optimization. Protein Expression and Purification 2010;74:272-9. [DOI: 10.1016/j.pep.2010.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
22 Singham J, Greanya ED, Lau K, Erb SR, Partovi N, Yoshida EM. Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence†. Annals of Hepatology 2010;9:166-71. [DOI: 10.1016/s1665-2681(19)31656-4] [Cited by in Crossref: 29] [Article Influence: 2.6] [Reference Citation Analysis]
23 Chen Y, Kong Y, Shi L, Zhang X, Yang X, Liu X, Lin S, Ye F. Study of the distribution of hepatitis B immunoglobulin in pregnant mice using small-animal imaging technology. J Med Virol 2019;91:1811-7. [PMID: 31209906 DOI: 10.1002/jmv.25521] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]